Measuring progress from 1990 to 2017 and projecting attainment to 2030 of the health-related Sustainable Development Goals for 195 countries and territories: a systematic analysis for the Global Burden of Disease Study 2017

TY - JOUR

T1 - Measuring progress from 1990 to 2017 and projecting attainment to 2030 of the health-related Sustainable Development Goals for 195 countries and territories

T2 - a systematic analysis for the Global Burden of Disease Study 2017

AU - GBD 2017 SDG Collaborators

AU - Lozano, Rafael

AU - Fullman, Nancy

AU - Abate, Degu

AU - Abay, Solomon M.

AU - Abbafati, Cristiana

AU - Abbasi, Nooshin

AU - Abbastabar, Hedayat

AU - Abd-Allah, Foad

AU - Abdela, Jemal

AU - Abdelalim, Ahmed

AU - Abdel-Rahman, Omar

AU - Abdi, Alireza

AU - Abdollahpour, Ibrahim

AU - Abdulkader, Rizwan Suliankatchi

AU - Abebe, Nebiyu Dereje

AU - Abebe, Zegeye

AU - Abejie, Ayenew Negesse

AU - Abera, Semaw F.

AU - Abil, Olifan Zewdie

AU - Aboyans, Victor

AU - Abraha, Haftom Niguse

AU - Abrham, Aklilu Roba

AU - Abu-Raddad, Laith Jamal

AU - Abu-Rmeileh, Niveen Me

AU - Abyu, Gebre Y.

AU - Accrombessi, Manfred Mario Kokou

AU - Acharya, Dilaram

AU - Acharya, Pawan

AU - Adamu, Abdu A.

AU - Adebayo, Oladimeji M.

AU - Adedeji, Isaac Akinkunmi

AU - Adedoyin, Rufus Adesoji

AU - Adekanmbi, Victor

AU - Adetokunboh, Olatunji O.

AU - Adhena, Beyene Meressa

AU - Adhikari, Tara Ballav

AU - Adib, Mina G.

AU - Adou, Arsène Kouablan

AU - Adsuar, Jose C.

AU - Afarideh, Mohsen

AU - Afshari, Mahdi

AU - Afshin, Ashkan

AU - Agarwal, Gina

AU - Aghayan, Sargis Aghasi

AU - Agius, Dominic

AU - Agrawal, Anurag

AU - Agrawal, Sutapa

AU - Ahmadi, Alireza

AU - Ahmadi, Mehdi

AU - Aremu, Olatunde

N1 - Funding Information: Ettore Beghi reports personal fees from Market Access Provider and grants from the Italian Ministry of Health, UCB, ALS Association, Eisai, and Shire. Yannick Bejot reports grants and personal fees from AstraZeneca and Boehringer Ingelheim and personal fees from Daiichi-Sankyo, Bristol-Myers Squibb, Pfizer, Medtronic, Bayer, Novex pharma, and Merck. Adam Berman reports personal fees from Philips. Louisa Degenhardt reports grants from Indivior, Mundipharma, and Seqirus. Cyrus Cooper reports personal fees from Alliance for Better Bone Health, Amgen, Eli Lilly, GlaxoSmithKline (GSK), Medtronic, Merck, Novartis, Pfizer, Roche, Servier, Takeda, and UCB. Mir Sohail Fazeli reports personal fees from Doctor Evidence. Panniyammakal Jeemon reports a clinical and public health intermediate fellowship from the Wellcome Trust-DBT India Alliance (2015–20). Jacek Jóźwiak reports grants and personal fees from Valeant, personal fees from ALAB Laboratoria and Amgen, and non-financial support from Microlife and Servier. Nicholas Kassebaum reports personal fees and other support from Vifor Pharmaceuticals. Jeffrey Lazarus reports personal fees from Janssen and Cepheid and grants and personal fees from AbbVie, Gilead Sciences, and Merck. Stefan Lorkowski reports personal fees from Amgen, Berlin-Chemie, Merck, Novo Nordisk, Sanofi-Aventis, Synlab, and Unilever, and non-financial support from Preventicus. Walter Mendoza is currently a program analyst for population and development at the Peru Country Office of the UN Population Fund, which does not necessarily endorse this study. Ted Miller reports an evaluation contract from AB InBev Foundation. Constance Dimity Pond reports personal fees from Nutricia advisory board, acting as an unpaid consultant to the Wicking Dementia Research and Education Centre in Tasmania for development of general practitioner (GP) education on dementia (airfares and accommodation paid), payment for acting as a dementia clinical lead and dementia pathways adviser for the Sydney North Primary Health Network, and payment for acting as a GP educator for Presbyterian Aged Care. Maarten Postma reports grants from Mundipharma, Bayer, Bristol-Myers Squibb, AstraZeneca, Arteg, and AscA; grants and personal fees from Sigma Tau, Merck, GSK, Pfizer, Boehringer Ingelheim, Novavax, Ingress Health, AbbVie, and Sanofi; personal fees from Quintiles, Astellas, Mapi, OptumInsight, Novartis, Swedish Orphan, Innoval, Jansen, Intercept, and Pharmerit; and stock ownership in Ingress Health and Pharmacoeconomics Advice Groningen. Kazem Rahimi reports grants from National Institute for Health Research Biomedical Research Centre, Economic and Social Research Council, and Oxford Martin School. Miloje Savic is employed by GSK Biologicals. Kenji Shibuya reports grants from Japanese Ministry of Health, Labour and Welfare and Ministry of Education, Culture, Sports, Science and Technology. Mark Shrime reports grants from Mercy Ships and Damon Runyon Cancer Research Foundation. Jasvinder Singh reports consulting for Horizon, Fidia, UBM, Medscape, WebMD, National Institutes of Health, and the American College of Rheumatology; serving as the principal investigator for an investigator-initiated study funded by Horizon Pharma through a grant to Dinora (a 501C3 non-profit organisation); and being on the steering committee of Outcome Measures in Rheumatology, an international organisation that develops measures for clinical trials and receives arms-length funding from 36 pharmaceutical companies. Jeffrey Stanaway reports a grant from Merck. Cassandra Szoeke reports a grant from the National Health and Medical Research Council (NHMRC), Lundbeck, Alzheimer's Association, and the Royal Australasian College of Practicioners; she holds patent PCT/AU2008/001556. Amanda Thrift reports grants NHMRC. Muthiah Vaduganathan receives research support from the National Heart, Lung and Blood Institute and serves as a consultant for Bayer and Baxter Healthcare. All other authors declare no competing interests. Funding Information: Research reported in this publication was supported by the Bill & Melinda Gates Foundation, the University of Melbourne, Public Health England, the Norwegian Institute of Public Health, St Jude Children's Research Hospital, the National Institute on Aging of the National Institutes of Health (award P30AG047845) , and the National Institute of Mental Health of the National Institutes of Health (award R01MH110163) . The content is solely the responsibility of the authors and does not necessarily represent the official views of the funders. We thank the Russia Longitudinal Monitoring Survey, done by the National Research University Higher School of Economics and ZAO Demoscope, together with Carolina Population Center, University of North Carolina at Chapel Hill, and the Institute of Sociology of the Russian Academy of Sciences, for making these data available. This analysis uses data or information from the Longitudinal Ageing Study in India (LASI). The development and release of the LASI pilot study was funded by the National Institute on Aging (R21AG032572, R03AG043052, and R01 AG030153) . Health Behaviour in School-aged Children (HBSC) is an international study performed in collaboration with the WHO Regional Office for Europe. The international coordinator of the 1997–98, 2001–02, 2005–06, and 2009–10 surveys was Candace Currie and the databank managers were Bente Wold for the 1997–98 survey and Oddrun Samdal for the following surveys. A list of principal investigators in each country can be found on the HBCS website . The Health and Retirement Study is sponsored by the National Institute on Aging (grant number NIA U01AG009740) and done by the University of Michigan. This research uses data from Add Health, a programme project designed by J Richard Udry, Peter S Bearman, and Kathleen Mullan Harris, and funded by grant P01-HD31921 from the Eunice Kennedy Shriver National Institute of Child Health and Human Development, with cooperative funding from 17 other agencies. Ronald R Rindfuss and Barbara Entwisle are acknowledged for their assistance in the original design of Add Health. People interested in obtaining data files from Add Health should contact Add Health, Carolina Population Center, Chapel Hill, NC, USA ( [email protected] ). No direct support was received from grant P01-HD31921 for this analysis. Researchers interested in using data from the Irish Longitudinal Study on Ageing can access the data for free from the Irish Social Science Data Archive at University College Dublin (http://www.ucd.ie/issda/data/tilda) and Interuniversity Consortium for Political and Social Research at the University of Michigan (http://www.icpsr.umich.edu/icpsrweb/ICPSR/studies/34315). Data for this study was provided by MEASURE Evaluation, which is funded by the United States Agency for International Development (USAID). Views expressed do not necessarily reflect those of USAID, the US Government, or MEASURE Evaluation. This research used data from the National Health Survey 2003. We are grateful to the Ministry of Health of Chile, the copyright owner of the survey, for giving us access to the database. All results of the study are those of the authors and in no way committed to the Ministry. The Palestinian Central Bureau of Statistics granted the researchers of GBD 2017 access to relevant data in accordance with licence number SLN2014-3-170, after subjecting data to processing aiming to preserve the confidentiality of individual data in accordance with the General Statistics Law, 2000. The researchers are solely responsible for the conclusions and inferences drawn from data from the Palestinian Central Bureau of Statistics. This paper uses data from SHARE waves 1, 2, 3 (SHARELIFE), 4, 5, and 6. Collection of data for that survey was primarily funded by the European Commission through framework programme (FP) 5 (QLK6-CT-2001-00360), FP6 (SHARE-I3: RII-CT-2006-062193; COMPARE: CIT5-CT-2005-028857; SHARELIFE: CIT4-CT-2006-028812), and FP7 (SHARE-PREP: number 211909; SHARE-LEAP: number 227822; SHARE M4: number 261982). Additional funding from the German Ministry of Education and Research, the Max Planck Society for the Advancement of Science, the US National Institute on Aging (U01_AG09740-13S2, P01_AG005842, P01_AG08291, P30_AG12815, R21_AG025169, Y1-AG-4553-01, IAG_BSR06-11, OGHA_04-064, HHSN271201300071C), and various national funding sources is gratefully acknowledged by SHARE. The Costa Rican Longevity and Healthy Aging Study (CRELES) is a longitudinal study by the University of Costa Rica's Centro Centroamericano de Población and Instituto de Investigaciones en Salud, in collaboration with the University of California at Berkeley. The original pre-1945 cohort was funded by the Wellcome Trust (grant 072406), and the 1945–55 Retirement Cohort was funded by the US National Institute on Aging (grant R01AG031716). The principal investigators of CRELES are Luis Rosero-Bixby and William H Dow, and the co-principal investigators are Xinia Fernández and Gilbert Brenes. We used data from the 2009–10 Ghana Socioeconomic Panel Study Survey, which is a nationally representative survey of more than 5000 households in Ghana. The survey is a joint effort undertaken by the Institute of Statistical, Social and Economic Research (ISSER) at the University of Ghana and the Economic Growth Center (EGC) at Yale University. It was funded by the EGC. ISSER and the EGC are not responsible for the estimations reported by the analysts. This study uses data from the WHO Study on global AGEing and adult health. Publisher Copyright: © 2018 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license

PY - 2018/11/10

Y1 - 2018/11/10

UR - http://www.scopus.com/inward/record.url?scp=85056168651&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85056168651&partnerID=8YFLogxK

U2 - 10.1016/S0140-6736(18)32281-5

DO - 10.1016/S0140-6736(18)32281-5

M3 - Article

C2 - 30496107

AN - SCOPUS:85056168651

SN - 0140-6736

VL - 392

SP - 2091

EP - 2138

JO - The Lancet

JF - The Lancet

IS - 10159

ER -